Last Updated : April 4, 2025
Details
FilesProject Status:
Complete
Therapeutic Area:
Non-Small Cell Lung Cancer (NSCLC) with Activating Epidermal Growth Factor Receptor (EGFR) Mutations
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0071-000
Final Recommendation/Report:
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | Feb 6, 2025 |
| Feedback Deadline: | Feb 13, 2025 |
| Final Report Posted: | Apr 4, 2025 |
Files
Last Updated : April 4, 2025